References
Arroyo V, Ginès P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996;23:164–176.
Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of the hepatorenal syndrome in cirrhosis: a consensus workshop of the International Ascites Club. Gut. 2007;56:1310–1318.
Olivera-Martínez M, Sayles H, Vivekanandadn R, D’Souza S, Florescu MC. Hepatorenal syndrome: are we missing some prognostic factors? Dig Dis Sci. 2012;57:210–214.
Boyer TD, Sanyal AJ, García-Tsao G, et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol. 2011;55:315–321.
Martin-Llahi M, Pepin MN, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008;134:1352–1359.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olivera-Martínez, M.A., Florescu, M.C. Hepatorenal Syndrome: Is It the Magnitude of the Renal Failure that Matters?. Dig Dis Sci 57, 1110–1111 (2012). https://doi.org/10.1007/s10620-012-2093-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-012-2093-8